Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification
暂无分享,去创建一个
E. Estey | C. Hourigan | J. Karp | M. Othus | A. Brunner | R. Swords | R. Hasserjian | A. DeZern | M. Percival | A. Ambinder | Michael J. Hochman